8-KEarnings & ResultsExhibits & Filings

JOHNSON & JOHNSON 8-K Report, Financial Results (Oct 18, 2005)

Filed October 18, 2005For Securities:JNJ

Summary

Johnson & Johnson (JNJ) filed an 8-K on October 18, 2005, to report its financial results for the third quarter ended October 2, 2005. The filing primarily includes a press release detailing the company's sales and earnings performance for the period. Investors should note that this report serves as a notification of the release of these financial figures, with the detailed information contained within the attached press release and supplementary financial data. This 8-K is important as it provides a snapshot of JNJ's operational and financial health during Q3 2005, enabling investors to assess the company's performance against expectations and prior periods. The attached exhibits are crucial for a thorough understanding of sales trends, profitability, and any significant financial developments that may impact the company's valuation and future outlook.

Key Highlights

  • 1JNJ filed an 8-K on October 18, 2005, reporting Q3 2005 financial results.
  • 2The report's primary purpose is to announce sales and earnings for the third quarter ended October 2, 2005.
  • 3Key financial details are provided via an attached press release (Exhibit 99.15).
  • 4Unaudited comparative supplementary sales data and condensed consolidated statements of earnings for Q3 are also included as Exhibit 99.20.
  • 5The filing signifies the public release of JNJ's latest financial performance metrics.
  • 6Investors can use this information to evaluate the company's recent financial health and operational progress.

Frequently Asked Questions

The main purpose of this 8-K filing by Johnson & Johnson on October 18, 2005, is to publicly report its sales and earnings results for the third quarter ended October 2, 2005. It serves as a formal notification to the SEC and investors about the release of these financial figures.

The detailed financial results for the third quarter ended October 2, 2005, are primarily found in the attached press release (Exhibit 99.15) and the unaudited comparative supplementary sales data and condensed consolidated statement of earnings (Exhibit 99.20) that are part of this 8-K filing.

This report covers the financial performance of Johnson & Johnson for the third quarter of its fiscal year, which ended on October 2, 2005.

The 8-K filing was signed on behalf of Johnson & Johnson by Stephen J. Cosgrove, Chief Accounting Officer, on October 18, 2005.